Pharmaceutical company GlaxoSmithKline may soon be able to offer a more effective shingles vaccine -- and it's produced ethically. Unlike the only other shingles vaccine available for use in the US, the new GSK vaccine, HZ/su, is not produced using cell lines derived from fetal cells. Currently, Merck holds the only license for a shingles vaccine in this country. That vaccine, Zostavax, is produced using cell lines that were grown from cells taken from a male fetus aborted at 14 weeks in the early 1960's.
The Church teaches that it is permissible to use unethically derived vaccines when no alternative is available, because using them constitutes, at most, "a form of very remote mediate...READ MORE